𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Toward the Validation of Functional Neuroimaging as a Potential Biomarker for Alzheimer’s Disease: Implications for Drug Development

✍ Scribed by Alberto Pupi; Lisa Mosconi; Flavio M. Nobili; Sandro Sorbi

Publisher
Springer-Verlag
Year
2005
Tongue
English
Weight
215 KB
Volume
7
Category
Article
ISSN
1536-1632

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytoplasmic domain of the β-amyloid prot
Cytoplasmic domain of the β-amyloid protein precursor of Alzheimer's disease: Function, regulation of proteolysis, and implications for drug development
✍ Megan L. Kerr; David H. Small 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 1 views

The ␤-amyloid protein precursor (APP) has been extensively studied for its role in amyloid production and the pathogenesis of Alzheimer's disease (AD). However, little is known about the normal function of APP and its biological interactions. In this Mini-Review, the role of the cytoplasmic domain o

Development of CDD-0102 as a selective M
Development of CDD-0102 as a selective M1 agonist for the treatment of Alzheimer's disease
✍ William S. Messer Jr.; Kenneth A. Bachmann; Colleen Dockery; Afif A. El-Assadi; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 1 views

## Abstract Selective muscarinic agonists might be useful in the treatment of Alzheimer's disease. To help characterize the activity and functional selectivity of two M~1~ muscarinic agonists, secretion of amyloid precursor protein, brain penetration, side effect profiles, cognition‐enhancing prope

The Caregiver Activity Survey (CAS): dev
The Caregiver Activity Survey (CAS): development and validation of a new measure for caregivers of persons with Alzheimer's disease
✍ Kenneth L. Davis; Deborah B. Marin; Robert Kane; Donald Patrick; Elaine R. Peski 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 3 views

## Background: Most instruments that measure the impairments associated with alzheimer's disease assess symptom severity. little attention has been paid to the illness's impact on the time formal and informal caregivers spend caring for alzheimer's individuals. a tool that measures the time spent c